Alpine Partners USVI’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Alpine Partners USVI’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$127K	Buy	+10,580	New	+$121K	0.42%	94

Other funds holding MNTA

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Alpine Partners USVI's MNTA Position: Q4 2014 in Review

Alpine Partners USVI opened a new position in Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2014: 10,580 shares worth $127K. The stake represents 0.42% of the portfolio and ranks #94 among its holdings.

148 funds tracked by Wall St. Rank hold MNTA as of Q4 2014.

Alpine Partners USVI held 10,580 shares of Momenta Pharmaceuticals, Inc. worth $127K as of Q4 2014.
Momenta Pharmaceuticals, Inc. was a new Alpine Partners USVI position in Q4 2014.
Momenta Pharmaceuticals, Inc. made up 0.42% of Alpine Partners USVI's portfolio in Q4 2014, its #94 holding.
148 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2014.

Based on Alpine Partners USVI's 13F filing for Q4 2014, filed 12 Feb 2015.